美乙肝组织呼吁社会重视乙肝研究,在美换肝需81.2万美元

2018-05-04 佚名 中新网

中新网5月4日电 据美国《世界日报》报道,近年来,在美国华人群体中,乙型肝炎患者人数居高不下。近日,一家乙肝防治组织与国会众议员孟昭文联手,呼吁政府、学术机构与制药厂商重视乙肝研究。孟昭文表示,身为国会病毒性肝炎委员会共同主席,她一直致力于对抗乙肝,近日为联邦疾病防治中心病毒性肝炎部门争取到500万美元新增经费,促进预防肝炎相关疾病。孟昭文指出,全球有2.92亿人罹患乙肝,每年有80万人因相关疾

中新网5月4日电 据美国《世界日报》报道,近年来,在美国华人群体中,乙型肝炎患者人数居高不下。近日,一家乙肝防治组织与国会众议员孟昭文联手,呼吁政府、学术机构与制药厂商重视乙肝研究。

孟昭文表示,身为国会病毒性肝炎委员会共同主席,她一直致力于对抗乙肝,近日为联邦疾病防治中心病毒性肝炎部门争取到500万美元新增经费,促进预防肝炎相关疾病。

孟昭文指出,全球有2.92亿人罹患乙肝,每年有80万人因相关疾病死亡,代表每天有2000人死于乙肝。在美国,约200万人患有慢性乙肝,毒品泛滥更使感染患者数量居高不下。社区民众需提升乙肝预防与筛检的意识。

该乙肝组织副总裁布朗斯坦(Alan Brownstein)指出,乙肝若恶化为肝硬化或肝癌,对家庭财务是极大的负担。在美国,换肝需要81.2万美元,治疗肝癌则需要4.65万美元,每年药物花费为8400美元至1.64万美元。

布朗斯坦说,目前没有药物能完全治愈慢性乙肝,但已有新药取得重大突破,可以治好丙肝,让研究乙肝的科学家重新燃起希望。

目前,该乙肝组织与联邦卫生总署合作共140项计划,牵涉病毒学、病毒治疗法、免疫学、肝癌研究等。

布拉克博士(Timothy Block)研究乙肝超过26年,近日,他公布一项研究计划,推出治疗乙肝计划书,包含研究目标、预算估计等,显示对抗乙肝是一场可打赢的战役。

布拉克提醒,卫生总署需要每年多拨3900万美元用于乙肝研究,如果无法维持拨款到2023年,后果将极为严重。“如果我们不能增加预算经费,那么到2030年,会有18.8万人死亡,占慢性肝炎患者的9.4%。”他表示,如果能提高拨款,到2030年,死亡人数能够降低至约17万人。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1808370, encodeId=d2aa18083e025, content=<a href='/topic/show?id=e2c68135281' target=_blank style='color:#2F92EE;'>#肝组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81352, encryptionId=e2c68135281, topicName=肝组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=856b247, createdName=songbq, createdTime=Mon Dec 17 02:41:00 CST 2018, time=2018-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313501, encodeId=96cc313501cc, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed May 09 13:06:03 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616855, encodeId=f3e0161685536, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Sun May 06 10:41:00 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312022, encodeId=3cf6312022b3, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Fri May 04 21:07:34 CST 2018, time=2018-05-04, status=1, ipAttribution=)]
    2018-12-17 songbq
  2. [GetPortalCommentsPageByObjectIdResponse(id=1808370, encodeId=d2aa18083e025, content=<a href='/topic/show?id=e2c68135281' target=_blank style='color:#2F92EE;'>#肝组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81352, encryptionId=e2c68135281, topicName=肝组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=856b247, createdName=songbq, createdTime=Mon Dec 17 02:41:00 CST 2018, time=2018-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313501, encodeId=96cc313501cc, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed May 09 13:06:03 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616855, encodeId=f3e0161685536, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Sun May 06 10:41:00 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312022, encodeId=3cf6312022b3, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Fri May 04 21:07:34 CST 2018, time=2018-05-04, status=1, ipAttribution=)]
    2018-05-09 大爰

    学习并分享!!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1808370, encodeId=d2aa18083e025, content=<a href='/topic/show?id=e2c68135281' target=_blank style='color:#2F92EE;'>#肝组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81352, encryptionId=e2c68135281, topicName=肝组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=856b247, createdName=songbq, createdTime=Mon Dec 17 02:41:00 CST 2018, time=2018-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313501, encodeId=96cc313501cc, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed May 09 13:06:03 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616855, encodeId=f3e0161685536, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Sun May 06 10:41:00 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312022, encodeId=3cf6312022b3, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Fri May 04 21:07:34 CST 2018, time=2018-05-04, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1808370, encodeId=d2aa18083e025, content=<a href='/topic/show?id=e2c68135281' target=_blank style='color:#2F92EE;'>#肝组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81352, encryptionId=e2c68135281, topicName=肝组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=856b247, createdName=songbq, createdTime=Mon Dec 17 02:41:00 CST 2018, time=2018-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313501, encodeId=96cc313501cc, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed May 09 13:06:03 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616855, encodeId=f3e0161685536, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Sun May 06 10:41:00 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312022, encodeId=3cf6312022b3, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Fri May 04 21:07:34 CST 2018, time=2018-05-04, status=1, ipAttribution=)]
    2018-05-04 changjiu

    学习一下谢谢

    0

相关资讯

慢性乙肝临床治愈“珠峰工程”启动 全国将落成25家示范基地医院

部分条件适合的患者应尽可能追求慢性乙肝的临床治愈。2015年发布的中国新版《慢性乙型肝炎防治指南》中如是强调。据2017年和2018年全国法定传染病疫情概况显示,全国病毒性乙肝平均每月新发病例无下降趋势。截至目前,全国慢性乙肝患者约2800万人。为提高各级医院的医生乙肝诊疗水平,探索、优化和完善临床治愈路径,2018年4月19日,370余名专家齐聚人民大会堂,正式启动由中国肝炎防治基金会发起设立的

J Gastroenterol Hepatol:乙肝核心相关抗原水平升高会增加肝硬化发生风险

HBV携带者的HBcrAg水平升高会增加肝硬化发生的风险。HBcrAg是肝硬化发展的良好预测因子

中科院:乙肝纤维化临床智能诊断获新突破

我国拥有近一亿的乙型肝炎病毒携带者,并占有全球超过50%的慢性乙肝患者,这长期成为我国严重的公共医疗卫生问题乃至社会问题。肝纤维化是慢性乙肝患者向肝硬化、肝癌逐步发展的病理学表现,其精准分期诊断是临床监视、治疗决策和预后评估的重要依据。然而,临床对于肝纤维化分期依赖于肝脏活组织穿刺检测。该方法不仅对患者具有身体创伤、副作用明显,而且难以重复使用,无法长期、动态监视患者病情的发展。因此,乙肝患者的临

J Viral Hepat:既往HBV感染影响增加了慢性丙型肝炎患者不良肝脏结果的风险

本研究是迄今为止最大的一项研究,表明既往HBV感染与慢性丙型肝炎患者不良肝脏结果的相关性。

病例分享:一例疑似隐匿性乙型肝炎的病例分享

某日老师发报告时发现一罕见病例,怀疑该患者可能为隐匿性乙型肝炎,于是我们开始查病历、看文献,想要研究透彻这一现象的本质,下面让我们带着几个问题来看这篇文章。

Radiology:抗病毒治疗在延缓慢性乙肝肝硬化进展的作用有多大呢?

本研究旨在探究声学辐射压力脉冲(ARFI)超声(US)成像在慢性乙肝患者的临床应用及纵向研究的价值,并将研究结果发表在Radiology上。